000 01641 a2200457 4500
005 20250516064459.0
264 0 _c20140930
008 201409s 0 0 eng d
022 _a1873-2623
024 7 _a10.1016/j.transproceed.2011.09.009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSuszynski, T M
245 0 0 _aAssessment of tissue-engineered islet graft viability by fluorine magnetic resonance spectroscopy.
_h[electronic resource]
260 _bTransplantation proceedings
_cNov 2011
300 _a3221-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCell Survival
650 0 4 _aDiabetes Mellitus, Type 1
_xtherapy
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFluorine
_xpharmacology
650 0 4 _aGraft Survival
650 0 4 _aHumans
650 0 4 _aIslets of Langerhans
_xcytology
650 0 4 _aIslets of Langerhans Transplantation
_xmethods
650 0 4 _aMagnetic Resonance Spectroscopy
_xmethods
650 0 4 _aModels, Theoretical
650 0 4 _aOxygen
_xmetabolism
650 0 4 _aOxygen Consumption
650 0 4 _aPartial Pressure
650 0 4 _aSwine
650 0 4 _aTissue Engineering
_xmethods
650 0 4 _aTissue Scaffolds
_xchemistry
700 1 _aAvgoustiniatos, E S
700 1 _aStein, S A
700 1 _aFalde, E J
700 1 _aHammer, B E
700 1 _aPapas, K K
773 0 _tTransplantation proceedings
_gvol. 43
_gno. 9
_gp. 3221-5
856 4 0 _uhttps://doi.org/10.1016/j.transproceed.2011.09.009
_zAvailable from publisher's website
999 _c21327060
_d21327060